Effects of diabetes-induced hyperglycemia in the heart

Biochemical and structural alterations

Tahreem Iqbal, Philip J. Welsby, Frank C. Howarth, Keshore R Bidasee, Ernest Adeghate, Jaipaul Singh

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hyperglycemia (HG) plays a major role in the development of diabetes mellitus (DM) and its complications. HG induces numerous maladaptations at the cellular level and moreover it is an independent risk factor to worsen cardiac performance and cell survival. The heart is a major target organ for damage with hyperglycemia. Alterations as a result of HG can lead to the development of a diabetic cardiomyopathy, resulting in changes to cardiac structure and function. Mechanisms damaging the heart are similar to those that damage the vasculature, but are more widespread in the myocardium. Four major pathways are implicated in HG-induced cardiac and vascular damage, including increases in advanced glycation end products (AGEs), enhanced hexosamine and polyol fl ux, and activation of classical isoforms of protein kinase C (PKC). These changes lead to abnormalities such as increased ventricular stiffness, cardiac fi brosis, derangement in cellular calcium ion homeostasis, and reduced myocyte contractility, resulting in heart failure (HF) over time. These pathways refl ect upon a single HG-induced process of overproduction of superoxide by the mitochondrial electron-transport chain, which is responsible for the changes occurring in the heart. This chapter discusses the HG-induced pathways, focusing on their effects on the structure of the diabetic heart, as well as examining the downstream signaling whereby oxidative stress leads to myocardial fi brosis and impaired contractile function. In addition, this review highlights the role of endothelin-1 (ET-1) in endothelial dysfunction and the effects of humoral factors, angiotensin II and transforming growth factor-ß, in evoking multiple signaling pathways in cardiac fi broblasts or fi brosis that leads to cardiac remodelling. How these signaling pathways mediated by HG contribute to the pathophysiological alterations in the heart is also discussed in this review.

Original languageEnglish (US)
Title of host publicationDiabetic Cardiomyopathy
Subtitle of host publicationBiochemical and Molecular Mechanisms
PublisherSpringer New York
Pages77-106
Number of pages30
ISBN (Electronic)9781461493174
ISBN (Print)9781461493167
DOIs
StatePublished - Jan 1 2014

Fingerprint

Medical problems
Hyperglycemia
Hexosamines
Advanced Glycosylation End Products
Oxidative stress
Diabetic Cardiomyopathies
Transforming Growth Factors
Endothelin-1
Superoxides
Angiotensin II
Protein Kinase C
Diabetes Complications
Electron Transport
Chemical activation
Cells
Stiffness
Ions
Muscle Cells
Calcium
Blood Vessels

Keywords

  • Cardiac remodelling
  • Diabetes mellitus
  • Diabetic cardiomyopathy
  • Endothelial cell dysfunction
  • Heart structure
  • Hyperglycemia
  • Signaling pathways

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Iqbal, T., Welsby, P. J., Howarth, F. C., Bidasee, K. R., Adeghate, E., & Singh, J. (2014). Effects of diabetes-induced hyperglycemia in the heart: Biochemical and structural alterations. In Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms (pp. 77-106). Springer New York. https://doi.org/10.1007/978-1-4614-9317-4_5

Effects of diabetes-induced hyperglycemia in the heart : Biochemical and structural alterations. / Iqbal, Tahreem; Welsby, Philip J.; Howarth, Frank C.; Bidasee, Keshore R; Adeghate, Ernest; Singh, Jaipaul.

Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms. Springer New York, 2014. p. 77-106.

Research output: Chapter in Book/Report/Conference proceedingChapter

Iqbal, T, Welsby, PJ, Howarth, FC, Bidasee, KR, Adeghate, E & Singh, J 2014, Effects of diabetes-induced hyperglycemia in the heart: Biochemical and structural alterations. in Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms. Springer New York, pp. 77-106. https://doi.org/10.1007/978-1-4614-9317-4_5
Iqbal T, Welsby PJ, Howarth FC, Bidasee KR, Adeghate E, Singh J. Effects of diabetes-induced hyperglycemia in the heart: Biochemical and structural alterations. In Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms. Springer New York. 2014. p. 77-106 https://doi.org/10.1007/978-1-4614-9317-4_5
Iqbal, Tahreem ; Welsby, Philip J. ; Howarth, Frank C. ; Bidasee, Keshore R ; Adeghate, Ernest ; Singh, Jaipaul. / Effects of diabetes-induced hyperglycemia in the heart : Biochemical and structural alterations. Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms. Springer New York, 2014. pp. 77-106
@inbook{f48f5d78a49c44bb866a4006cdb9d851,
title = "Effects of diabetes-induced hyperglycemia in the heart: Biochemical and structural alterations",
abstract = "Hyperglycemia (HG) plays a major role in the development of diabetes mellitus (DM) and its complications. HG induces numerous maladaptations at the cellular level and moreover it is an independent risk factor to worsen cardiac performance and cell survival. The heart is a major target organ for damage with hyperglycemia. Alterations as a result of HG can lead to the development of a diabetic cardiomyopathy, resulting in changes to cardiac structure and function. Mechanisms damaging the heart are similar to those that damage the vasculature, but are more widespread in the myocardium. Four major pathways are implicated in HG-induced cardiac and vascular damage, including increases in advanced glycation end products (AGEs), enhanced hexosamine and polyol fl ux, and activation of classical isoforms of protein kinase C (PKC). These changes lead to abnormalities such as increased ventricular stiffness, cardiac fi brosis, derangement in cellular calcium ion homeostasis, and reduced myocyte contractility, resulting in heart failure (HF) over time. These pathways refl ect upon a single HG-induced process of overproduction of superoxide by the mitochondrial electron-transport chain, which is responsible for the changes occurring in the heart. This chapter discusses the HG-induced pathways, focusing on their effects on the structure of the diabetic heart, as well as examining the downstream signaling whereby oxidative stress leads to myocardial fi brosis and impaired contractile function. In addition, this review highlights the role of endothelin-1 (ET-1) in endothelial dysfunction and the effects of humoral factors, angiotensin II and transforming growth factor-{\ss}, in evoking multiple signaling pathways in cardiac fi broblasts or fi brosis that leads to cardiac remodelling. How these signaling pathways mediated by HG contribute to the pathophysiological alterations in the heart is also discussed in this review.",
keywords = "Cardiac remodelling, Diabetes mellitus, Diabetic cardiomyopathy, Endothelial cell dysfunction, Heart structure, Hyperglycemia, Signaling pathways",
author = "Tahreem Iqbal and Welsby, {Philip J.} and Howarth, {Frank C.} and Bidasee, {Keshore R} and Ernest Adeghate and Jaipaul Singh",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-9317-4_5",
language = "English (US)",
isbn = "9781461493167",
pages = "77--106",
booktitle = "Diabetic Cardiomyopathy",
publisher = "Springer New York",

}

TY - CHAP

T1 - Effects of diabetes-induced hyperglycemia in the heart

T2 - Biochemical and structural alterations

AU - Iqbal, Tahreem

AU - Welsby, Philip J.

AU - Howarth, Frank C.

AU - Bidasee, Keshore R

AU - Adeghate, Ernest

AU - Singh, Jaipaul

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Hyperglycemia (HG) plays a major role in the development of diabetes mellitus (DM) and its complications. HG induces numerous maladaptations at the cellular level and moreover it is an independent risk factor to worsen cardiac performance and cell survival. The heart is a major target organ for damage with hyperglycemia. Alterations as a result of HG can lead to the development of a diabetic cardiomyopathy, resulting in changes to cardiac structure and function. Mechanisms damaging the heart are similar to those that damage the vasculature, but are more widespread in the myocardium. Four major pathways are implicated in HG-induced cardiac and vascular damage, including increases in advanced glycation end products (AGEs), enhanced hexosamine and polyol fl ux, and activation of classical isoforms of protein kinase C (PKC). These changes lead to abnormalities such as increased ventricular stiffness, cardiac fi brosis, derangement in cellular calcium ion homeostasis, and reduced myocyte contractility, resulting in heart failure (HF) over time. These pathways refl ect upon a single HG-induced process of overproduction of superoxide by the mitochondrial electron-transport chain, which is responsible for the changes occurring in the heart. This chapter discusses the HG-induced pathways, focusing on their effects on the structure of the diabetic heart, as well as examining the downstream signaling whereby oxidative stress leads to myocardial fi brosis and impaired contractile function. In addition, this review highlights the role of endothelin-1 (ET-1) in endothelial dysfunction and the effects of humoral factors, angiotensin II and transforming growth factor-ß, in evoking multiple signaling pathways in cardiac fi broblasts or fi brosis that leads to cardiac remodelling. How these signaling pathways mediated by HG contribute to the pathophysiological alterations in the heart is also discussed in this review.

AB - Hyperglycemia (HG) plays a major role in the development of diabetes mellitus (DM) and its complications. HG induces numerous maladaptations at the cellular level and moreover it is an independent risk factor to worsen cardiac performance and cell survival. The heart is a major target organ for damage with hyperglycemia. Alterations as a result of HG can lead to the development of a diabetic cardiomyopathy, resulting in changes to cardiac structure and function. Mechanisms damaging the heart are similar to those that damage the vasculature, but are more widespread in the myocardium. Four major pathways are implicated in HG-induced cardiac and vascular damage, including increases in advanced glycation end products (AGEs), enhanced hexosamine and polyol fl ux, and activation of classical isoforms of protein kinase C (PKC). These changes lead to abnormalities such as increased ventricular stiffness, cardiac fi brosis, derangement in cellular calcium ion homeostasis, and reduced myocyte contractility, resulting in heart failure (HF) over time. These pathways refl ect upon a single HG-induced process of overproduction of superoxide by the mitochondrial electron-transport chain, which is responsible for the changes occurring in the heart. This chapter discusses the HG-induced pathways, focusing on their effects on the structure of the diabetic heart, as well as examining the downstream signaling whereby oxidative stress leads to myocardial fi brosis and impaired contractile function. In addition, this review highlights the role of endothelin-1 (ET-1) in endothelial dysfunction and the effects of humoral factors, angiotensin II and transforming growth factor-ß, in evoking multiple signaling pathways in cardiac fi broblasts or fi brosis that leads to cardiac remodelling. How these signaling pathways mediated by HG contribute to the pathophysiological alterations in the heart is also discussed in this review.

KW - Cardiac remodelling

KW - Diabetes mellitus

KW - Diabetic cardiomyopathy

KW - Endothelial cell dysfunction

KW - Heart structure

KW - Hyperglycemia

KW - Signaling pathways

UR - http://www.scopus.com/inward/record.url?scp=85028512945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028512945&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-9317-4_5

DO - 10.1007/978-1-4614-9317-4_5

M3 - Chapter

SN - 9781461493167

SP - 77

EP - 106

BT - Diabetic Cardiomyopathy

PB - Springer New York

ER -